Clinical significance of surgical treatment for imatinib-resistant gastrointestinal stromal tumors.

被引:0
|
作者
Hashimoto, Tadayoshi [1 ]
Takahashi, Tsuyoshi [1 ]
Kurokawa, Yukinori [1 ]
Kato, Ryo [1 ]
Wada, Noriko [1 ]
Tanaka, Koji [1 ]
Miyazaki, Yasuhiro [1 ]
Makino, Tomoki [1 ]
Yamasaki, Makoto [1 ]
Nakajima, Kiyokazu [1 ]
Mori, Masaki [1 ]
Doki, Yuichiro [1 ]
机构
[1] Osaka Univ, Grad Sch Med, Osaka, Japan
关键词
D O I
10.1200/JCO.2018.36.4_suppl.189
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
189
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Novel V600E BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors
    Agaram, Narasimhan P.
    Wong, Grace C.
    Guo, Tianhua
    Maki, Robert G.
    Singer, Samuel
    DeMatteo, Ronald P.
    Besmer, Peter
    Antonescu, Cristina R.
    GENES CHROMOSOMES & CANCER, 2008, 47 (10): : 853 - 859
  • [32] A Phase I Study of Single-Agent Nilotinib or in Combination with Imatinib in Patients with Imatinib-Resistant Gastrointestinal Stromal Tumors
    Demetri, George D.
    Casali, Paolo G.
    Blay, Jean-Yves
    von Mehren, Margaret
    Morgan, Jeffrey A.
    Bertulli, Rossella
    Ray-Coquard, Isabelle
    Cassier, Philippe
    Davey, Monica
    Borghaei, Hossein
    Pink, Daniel
    Debiec-Rychter, Maria
    Cheung, Wing
    Bailey, Stuart M.
    Veronese, Maria Luisa
    Reichardt, Annette
    Fumagalli, Elena
    Reichardt, Peter
    CLINICAL CANCER RESEARCH, 2009, 15 (18) : 5910 - 5916
  • [33] Surgical Treatment of Gastrointestinal Stromal Tumors Located in the Stomach in the Imatinib Era
    Stiekema, Jurrien
    Kol, Sabrine
    Cats, Annemieke
    Yazdi, Amir T.
    van Coevorden, Frits
    van Sandick, Johanna W.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2015, 38 (05): : 502 - 507
  • [34] Gastrointestinal stromal tumors. Diagnosis and treatment
    Acin-Gandara, Debora
    Pereira-Perez, Fernando
    Castano-Pascual, Angel
    Duran-Poveda, Manuel
    Antequera-Perez, Alfonso
    Miliani-Molina, Carlos
    CIRUGIA Y CIRUJANOS, 2012, 80 (01): : 42 - 49
  • [35] Imatinib-Resistant Gastrointestinal Stromal Tumor Presenting as a Large Abdominal Mass
    Haider, Asim
    Mehershahi, Shehriyar
    Siddiqa, Ayesha
    Sharma, Madhav
    Patel, Harish
    CASE REPORTS IN GASTROENTEROLOGY, 2021, 15 (02) : 736 - 741
  • [36] Combination of pimitespib (TAS-116) with sunitinib is an effective therapy for imatinib-resistant gastrointestinal stromal tumors
    Teranishi, Ryugo
    Takahashi, Tsuyoshi
    Obata, Yuuki
    Nishida, Toshirou
    Ohkubo, Shuichi
    Kazuno, Hiromi
    Saito, Yurina
    Serada, Satoshi
    Fujimoto, Minoru
    Kurokawa, Yukinori
    Saito, Takuro
    Yamamoto, Kazuyoshi
    Yamashita, Kotaro
    Tanaka, Koji
    Makino, Tomoki
    Nakajima, Kiyokazu
    Hirota, Seiichi
    Naka, Tetsuji
    Eguchi, Hidetoshi
    Doki, Yuichiro
    INTERNATIONAL JOURNAL OF CANCER, 2023, 152 (12) : 2580 - 2593
  • [37] Novel receptor tyrosine kinase targeted combination therapies for imatinib-resistant gastrointestinal stromal tumors (GIST)
    Mahadevan, Daruka
    Theiss, Noah
    Morales, Carla
    Stejskal, Amy E.
    Cooke, Laurence S.
    Zhu, Min
    Kurtzman, Drew
    Swart, Rachel
    Ong, Evan
    Qi, Wenqing
    ONCOTARGET, 2015, 6 (04) : 1954 - 1966
  • [38] A phase I study of nilotinib alone and in combination with imatinib in patients with imatinib-resistant gastrointestinal stromal tumors (GIST): Study update
    Blay, J. Y.
    Casali, P. G.
    Reichardt, P.
    von Mehren, M.
    Debiec-Rychter, M.
    Bailey, S.
    Veronese, M. L.
    Demetri, G. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [39] Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants
    Debiec-Rychter, M
    Cools, J
    Dumez, H
    Sciot, R
    Stul, M
    Mentens, N
    Vranckx, H
    Wasag, B
    Prenen, H
    Roesel, J
    Hagemeijer, A
    Van Oosterom, A
    Marynen, P
    GASTROENTEROLOGY, 2005, 128 (02) : 270 - 279
  • [40] Gastrointestinal stromal tumors.
    Casper E.S.
    Current Treatment Options in Oncology, 2000, 1 (3) : 267 - 273